Evidence map›Paper›PMID 29845507›Full record

ArticleJournal of medical toxicology : official journal of the American College of Medical Toxicology2018

Telemedicine Delivery and Successful Reimbursement in Toxicology.

Peter W Crane, Timothy J Wiegand, Michael Kamali, Marilynn Reif, Rose Wratni, Ronald Montante, Tracey Loveland

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Methods of Reimbursement for Telemedicine Services: A Scoping Review.Medical journal of the Islamic Republic of Iran · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Peter W CraneUniversity of Rochester, Rochester, NY, USA. cranep1@simon.rochester.edu.ORCID 0000-0002-6657-1135
Timothy J WiegandUniversity of Rochester, Rochester, NY, USA.
Michael KamaliUniversity of Rochester, Rochester, NY, USA.
Marilynn ReifUniversity of Rochester, Rochester, NY, USA.
Rose WratniUniversity of Rochester, Rochester, NY, USA.
Ronald MontanteUniversity of Rochester, Rochester, NY, USA.
Tracey LovelandUniversity of Rochester, Rochester, NY, USA.
University of Rochester · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTelemedicine and its use in medical toxicology have existed for some time. There are varied definitions, but existing ones center on using currently available forms of audio, video, and internet communications to provide "real-time" patient care. Definitions have historically limited reimbursement but recently expanded CMS guidelines have improved this. Here we describe our experience with telemedicine and reimbursement.

methodsA retrospective study was conducted of all toxicology and billing reimbursement for fiscal year 2016 for a solo Medical Toxicology service. Clinical identifiers were used to match telemedicine consults to hospital financial databases and then removed. Telemedicine consults were isolated, quantified, and described.

resultsA total of 16 telemedicine consults were conducted. Average age was 37.2 (range 2 months-82 years). Gender was evenly split at 8:8. Twenty-five percent were pediatric consultations. The main purposes of consultation were as follows: diagnosis and disease management in drug ingestion, triage assistance, clearance consults, antidote administration, and buprenorphine induction. At the time of the work, $1896.00 for 9.3 h of teletoxicology services was reimbursed equating to an hourly reimbursement rate of $203.90/h. LIMITATIONS: Our data was obtained from a toxicology practice with a surrounding infrastructure dedicated to telemedicine. All sites may not have this robust ancillary support. Furthermore, not all states have reimbursement mandates such as New York State.

conclusionTo our knowledge, this is the first published work describing pilot data in the successful reimbursement for Medical Toxicology services delivered via telemedicine. Toxicology via telemedicine represents a great opportunity for advancing the practice of toxicology in an economically feasible way, particularly in rural or underserved areas.

Indexed as

Insurance, Health, ReimbursementAdolescentAdultAgedAged, 80 and overAntidotesCosts and Cost AnalysisDelivery of Health CareFemaleHumansInfantMaleMiddle AgedPilot ProjectsPoisoningReferral and ConsultationAntidotesBillingChargesCompensationReimbursementTelemedicineTeletoxicologyToxicology

Identifiers

PMID29845507
PMCPMC6097969
OpenAlexW2805637737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.